These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 5819104)

  • 21. [A major intolerance reaction related to the injection of modified fluid gelatin. Apropos of 1 case].
    Benbunan M; Pavie-Fischer J; Reviron J
    Anesth Analg (Paris); 1976; 3(4):709-12. PubMed ID: 1015657
    [No Abstract]   [Full Text] [Related]  

  • 22. A study of safer plasma substitutes.
    Gollub S; Vanichanan C; Schaefer C; Schechter DC
    Surg Gynecol Obstet; 1969 Jun; 128(6):1235-43. PubMed ID: 5781849
    [No Abstract]   [Full Text] [Related]  

  • 23. [Undesirable effects of macromolecules].
    Hint H
    Anesth Analg (Paris); 1976; 3(4):703-7. PubMed ID: 1015656
    [No Abstract]   [Full Text] [Related]  

  • 24. A case of hypersensitivity to gelafundin.
    Ong EL
    Singapore Med J; 2001 Apr; 42(4):176-7. PubMed ID: 11465319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Red cell aggregation induced by a high molecular weight gelatin plasma substitute.
    Scholz PM; Engeset J; Matheson NA; Gruber UF
    Eur Surg Res; 1971; 3(6):428-35. PubMed ID: 5158956
    [No Abstract]   [Full Text] [Related]  

  • 26. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis.
    Gosling P; Rittoo D; Manji M; Mahmood A; Vohra R
    Lancet; 2001 Aug; 358(9281):581; author reply 582. PubMed ID: 11526921
    [No Abstract]   [Full Text] [Related]  

  • 27. Pseudoproteinuria following gelatin infusion.
    Hordijk W; Klasen IS; de Keijzer MH; Branten AJ; Wetzels JF
    Nephrol Dial Transplant; 1999 Nov; 14(11):2782-3. PubMed ID: 10534538
    [No Abstract]   [Full Text] [Related]  

  • 28. Transient massive proteinuria after gelatin-derived plasma expander (Gelofusine®) administration.
    Raghunath V; Marshall G; Ratanjee SK; Francis RS
    Nephrology (Carlton); 2013 Mar; 18(3):240-1. PubMed ID: 23432751
    [No Abstract]   [Full Text] [Related]  

  • 29. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis.
    Godet G
    Lancet; 2001 Aug; 358(9281):581; author reply 582. PubMed ID: 11526922
    [No Abstract]   [Full Text] [Related]  

  • 30. [Anaphylactoid reaction to Physiogel SRK 4%--a contribution to the controversy about plasma substitutes].
    Cron TA; Gerber H
    Schweiz Med Wochenschr; 1991 Nov; 121(48):1773-6. PubMed ID: 1688371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute renal failure after infusion of gelatins.
    Hussain SF; Drew PJ
    BMJ; 1989 Nov; 299(6708):1137-8. PubMed ID: 2513022
    [No Abstract]   [Full Text] [Related]  

  • 32. [Reducing of unwanted side effects of modified fluid gelatin by promethazine: controlled clinical trial with orthopaedic patints (author's transl)].
    Schöning B; Koch H
    Anaesthesist; 1981 Jan; 30(1):34-43. PubMed ID: 7469003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The bleeding tendency associated with plasma expanders.
    Gollub S; Schaefer C; Squitieri A
    Surg Gynecol Obstet; 1967 Jun; 124(6):1203-11. PubMed ID: 6024198
    [No Abstract]   [Full Text] [Related]  

  • 34. The use of basophil activation to diagnose allergy to Gelofusine.
    Shields MO; Mirakhur RK; Crockard AD; Edgar JD
    Anaesthesia; 2006 Jul; 61(7):716-7; author reply 717-8. PubMed ID: 16792624
    [No Abstract]   [Full Text] [Related]  

  • 35. Acute oligoanuric renal failure in dextran 40 treated patients.
    Frey L; Messmer K
    Ren Fail; 1998 May; 20(3):543-5. PubMed ID: 9606743
    [No Abstract]   [Full Text] [Related]  

  • 36. [Death from anaphylactic shock in polyglucin transfusion].
    Ruban GE
    Sud Med Ekspert; 1981; 24(2):57. PubMed ID: 6166106
    [No Abstract]   [Full Text] [Related]  

  • 37. [Concerning: "Anaphylactoid reaction to Physiogel SRK 4%--a contribution to the controversy on plasma substitute agents" by T.A. Cron and H. Gerber (Schweiz. med. Wschr. 1991; 127: 1773-1776)].
    Schmid P; Huwyler T; Wüthrich B
    Schweiz Med Wochenschr; 1992 Oct; 122(41):1544-5. PubMed ID: 1411414
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparison of dextran and gelatin as plasma substitutes].
    Lundsgaard-Hansen P; Riedwyl H; Hässig A
    Anaesthesist; 1967 Jul; 16(7):206-15. PubMed ID: 4872538
    [No Abstract]   [Full Text] [Related]  

  • 39. [Anaphylactic shock after infusion of a modified gelatin solution. Hemodynamic study].
    Blanloeil Y; Pinaud M; Villers D; Nicolas F
    Nouv Presse Med; 1982 Oct; 11(38):2847-8. PubMed ID: 7177819
    [No Abstract]   [Full Text] [Related]  

  • 40. [Side effects of colloidal plasma substitutes].
    Bergmann H
    Beitr Infusionther Klin Ernahr; 1981; 8():33-42. PubMed ID: 6172109
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.